Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Krzysztof Palczewski
University of California Irvine, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Polgenix
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research focuses on the chief commercial platforms of Polgenix, including understanding the chemistry and genetics of the retinoid cycle; and also describes use of the 2-photon ophthalmoscope.
Retinoids in Vision
NARRATIVE The retinoid (visual) cycle is a fundamental set of reactions necessary to regenerate the visual chromophore, 11-cis-retinal and sustain vision. Genetic or environmental factors affecting chromophore production can lead to blindness. We aim to advance our understanding of the retinoid cycle and to develop strategies to stop progression of human retinal diseases using animal models related to this metabolic transformation. Pharmacologic interventions to save vision are now within reach due to a significantly improved understanding of these chemical transformations.
Filed on June 12, 2019.
Tell us what you know about Krzysztof Palczewski's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Krzysztof Palczewski filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | $150,000 - $199,999 |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | $150,000 - $199,999 |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | $150,000 - $199,999 |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | $80,000 - $99,999 |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | University of California Irvine | Conflict of Interest | Polgenix | Value cannot be readily determined |
| Krzysztof Palczewski | Case Western Reserve University | Conflict of Interest | Polgenix | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.